Robot maker · early
LivsMed
Korean surgical-device maker commercializing ArtiSential articulating laparoscopic instruments since 2018 and now building the STARK laparoscopic surgical robot. STARK's telesurgery capability was demonstrated in a July 2025 wet-lab feasibility study with Sovato (console in Santa Barbara operating a system in Chicago); animal trials began May 2026 with MFDS approval filing planned within the year and a dedicated robot factory slated for late 2027. Completed the largest KOSDAQ IPO of the 2025 cycle in January 2026 to fund robotic and US expansion.
Company overview
Identity and operating footprint
Robot models
Specifications remain vendor-claimed
STARK surgical robot
- Laparoscopic surgical robot with telesurgery capability; remote wet-lab surgery demonstrated with surgeon console in Santa Barbara, CA and robot in Chicago, IL via Sovato platform (July 2025)
early-feasibility remote-surgery demonstration of the robot system
Claim source
Funding history
Publicly announced rounds
KOSDAQ IPO
Investors undisclosed
Round sourceCompany timeline
Milestones and announcements
Source ledger
2 unique public sources